@article{e82f3f16851d45239d0d9c387012bcd3,
title = "Novel and emerging innate immune therapeutic targets for pancreatic cancer",
keywords = "Innate immune, STING, agonist, cyclic GMP-AMP synthase (cGAS), cyclic dinucleotides (CDNs), immune therapy, pancreatic cancer",
author = "Liang Wang and Imad Shureiqi and Stroehlein, {John R.} and Daoyan Wei",
note = "Funding Information: This paper was funded in part by the NIH/NCI under award number [P30CA016672] and The University of Texas MD Anderson Cancer Center Institutional Research program.",
year = "2018",
month = dec,
day = "2",
doi = "10.1080/14728222.2018.1538361",
language = "English (US)",
volume = "22",
pages = "977--981",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",
number = "12",
}